These ligands bind to TRAIL receptors 1 and 2 (TRAIL-R1/-R2) or the CD95/Fas receptor on target cells, ultimately inducing cell death [172]
Some people taking GLP-1 medications notice they feel thirstier or produce less saliva
Although hair loss and and GLP-1 medications are linked, it's not the medication that directly causes the hair loss
These multifaceted effects position GLP-1RAs as a promising therapeutic option in MASLD, thus warranting further investigation through clinical trials
Those products are not the same as a studied pharmaceutical product
They are part of a medical approach to weight management for people struggling with obesity, insulin resistance, metabolic health concerns, appetite control, weight regain, or difficulty maintaining results